Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness | Researchclopedia
Back to research
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
2020
1,622 citations
Journal Article
bronze Open Access
Field-Weighted Citation Impact:
30.35
·
Moderna Therapeutics (United States)
Alexandra Schäfer
·
University of North Carolina at Chapel Hill
Cynthia T. Ziwawo
·
National Institutes of Health
Anthony DiPiazza
·
National Institutes of Health
Kenneth H. Dinnon
·
University of North Carolina at Chapel Hill
Sayda M. Elbashir
·
Moderna Therapeutics (United States)
Christine A. Shaw
·
Moderna Therapeutics (United States)
Angela Woods
·
Moderna Therapeutics (United States)
Ethan J. Fritch
·
University of North Carolina at Chapel Hill
David R. Martinez
·
University of North Carolina at Chapel Hill
Kevin W. Bock
·
National Institutes of Health
Mahnaz Minai
·
National Institutes of Health
Bianca M. Nagata
·
National Institutes of Health
Geoffrey B. Hutchinson
·
National Institutes of Health
Kaichun Wu
·
Moderna Therapeutics (United States)
Carole Henry
·
Moderna Therapeutics (United States)
Kapil Bahl
·
Moderna Therapeutics (United States)
Dario Garcia-Dominguez
·
Moderna Therapeutics (United States)
LingZhi Ma
·
Moderna Therapeutics (United States)
Isabella Renzi
·
Moderna Therapeutics (United States)
Wing-Pui Kong
·
National Institutes of Health
Stephen D. Schmidt
·
National Institutes of Health
Lingshu Wang
·
National Institutes of Health
Yi Zhang
·
National Institutes of Health
Emily Phung
·
National Institutes of Health
Lauren A. Chang
·
National Institutes of Health
Rebecca J. Loomis
·
National Institutes of Health
Nedim Emil Altaras
·
Moderna Therapeutics (United States)
Elisabeth Narayanan
·
Moderna Therapeutics (United States)
Mihir Metkar
·
Moderna Therapeutics (United States)
Vladimir Presnyak
·
Moderna Therapeutics (United States)
Cuiping Liu
·
National Institutes of Health
Mark K. Louder
·
National Institutes of Health
Wei Shi
·
National Institutes of Health
Kwanyee Leung
·
National Institutes of Health
Eun Sung Yang
·
National Institutes of Health
Ande West
·
University of North Carolina at Chapel Hill
Kendra L. Gully
·
University of North Carolina at Chapel Hill
Laura J. Stevens
·
Vanderbilt University Medical Center
Nianshuang Wang
·
The University of Texas at Austin
Daniel Wrapp
·
The University of Texas at Austin
Nicole A. Doria‐Rose
·
National Institutes of Health
Guillaume Stewart-Jones
·
Moderna Therapeutics (United States)
Hamilton Bennett
·
Moderna Therapeutics (United States)
Gabriela Alvarado
·
National Institutes of Health
Martha Nason
·
National Institutes of Health
Tracy J. Ruckwardt
·
National Institutes of Health
Jason S. McLellan
·
The University of Texas at Austin
Mark R. Denison
·
Vanderbilt University Medical Center
James D. Chappell
·
Vanderbilt University Medical Center
Ian N. Moore
·
National Institutes of Health
Kaitlyn M. Morabito
·
National Institutes of Health
John R. Mascola
·
National Institutes of Health
Ralph S. Baric
·
University of North Carolina at Chapel Hill
Andrea Carfı́
·
Moderna Therapeutics (United States)
Barney S. Graham
·
National Institutes of Health